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LETTERS
Structural basis of Na1-independent and cooperative
substrate/product antiport in CaiT
Sabrina Schulze1, Stefan Ko¨ster1, Ulrike Geldmacher1, Anke C. Terwisscha van Scheltinga1{&Werner Ku¨hlbrandt1
Transport of solutes across biological membranes is performed by
specialized secondary transport proteins in the lipid bilayer1, and
is essential for life. Here we report the structures of the sodium-
independent carnitine/butyrobetaine antiporter CaiT from Proteus
mirabilis (PmCaiT) at 2.3-A˚ and fromEscherichia coli (EcCaiT) at 3.5-
A˚ resolution. CaiT belongs to the family of betaine/carnitine/choline
transporters (BCCT), which are mostly Na1 or H1 dependent,
whereas EcCaiT isNa1 andH1 independent2. The three-dimensional
architecture of CaiT resembles that of the Na1-dependent trans-
porters LeuT3 and BetP4, but in CaiT a methionine sulphur takes
the place of the Na1 ion to coordinate the substrate in the central
transport site, accounting forNa1-independent transport. BothCaiT
structures show the fully open, inward-facing conformation, and
thus complete the set of functional states that describe the alterna-
ting access mechanism5. EcCaiT contains two bound butyrobetaine
substrate molecules, one in the central transport site, the other in
an extracellular binding pocket. In the structure of PmCaiT, a
tryptophan side chain occupies the transport site, and access to the
extracellular site is blocked. Binding of both substrates to CaiT
reconstituted into proteoliposomes is cooperative, with Hill coeffi-
cients up to 1.7, indicating that the extracellular site is regulatory.
We propose a mechanism whereby the occupied regulatory site
increases the binding affinity of the transport site and initiates
substrate translocation.
The three protomers of the CaiT trimer6 crystallized in an inward-
facing, fully open conformation. The cytoplasmic side of the proto-
mer shows a funnel approximately 25 A˚ deep and 15 A˚ wide that
narrows to roughly 7 A˚ in the centre (Fig. 1a). Access to the central
transport site from the cytoplasm is unhindered by obstructing side
chains. As in the related BetP4, the central transport site is a trypto-
phan box (Fig. 1b, c), defined by Trp 142 and Trp 147 from the partly
unwound fourth transmembrane helix (TM4), and Trp 323 and
Trp 324 from the continuous but highly tilted TM8. Outside access
is blocked by Trp 107 (TM3), Trp 316 (TM8) and Tyr 320 (TM8),
which is hydrogen bonded to the carboxyl group of Glu 111 (Fig. 2a).
Hydrophobic contacts between TM3, TM5, TM8 and TM12 help to
seal the channel towards the outside (Fig. 2a). As expected from 87%
sequence identity (Supplementary Fig. 1), the overall structures of
PmCaiT and EcCaiT resemble one another closely (Supplementary
Table 1).
The transport site of EcCaiT contains a bound c-butyrobetaine
substrate (Fig. 1b), carried over from the expression host, held in place
by cation–p interactions characteristic of proteins that bindquaternary
ammonium substrates7–10. In EcCaiT, the indole ring of Trp 323 in
TM8 is well placed for this interaction. The other residues in the trans-
port site hold the substrate by van der Waals contacts. In contrast, the
transport site of PmCaiT does not contain bound substrate. The side
chain of Trp 323 is rotated by 60u to a position that leaves no room for
either substrate (Fig. 1c). The orientation of Trp 323 is the most strik-
ing difference between the two CaiT structures.
Unlike BetP and LeuT, CaiT is Na1 independent. This is explained
by a comparison of the positions of side chains or ions that coordi-
nate the substrate. LeuT contains twoNa1 ions3. Na1 coordinates the
substrate in the transport site and stabilizes the unwound region of
TM6. Na2 stabilizes the unwound stretch of TM1, equivalent to TM3
in CaiT (Supplementary Table 2). The Na2 position in CaiT is occu-
pied by Arg 262 (TM7) (Fig. 2b). The positive charge links TM3 to
TM10 and stabilizes the unwound TM3, which contributes to sub-
strate-binding in the external binding pocket through Tyr 114
(Fig. 1d).
In sodium-dependent BetP, Na1 coordinates the betaine sub-
strate4. Neither CaiT structure shows a Na1 ion in this vicinity.
Instead, there is an attractive interaction between the carboxyl group
of the c-butyrobetaine, and the sulphur of Met 331 (Fig. 1b). This
methionine is conserved in CaiT and mammalian organic cation/
carnitine transporter (OCTN) transporters, but not in BetP (Sup-
plementary Fig. 1). The methionine sulphur in CaiT evidently takes
over the role Na1. Interestingly, ApcT, which is H1 but not Na1
dependent, also has a methionine in this position, whereas Na2 is
replacedby a lysine11. BothNa1-independent transporters thus stabilize
the unwound TM3 with a positively charged side chain, and have
replaced Na1 by a methionine sulphur.
A second c-butyrobetaine is bound in an extracellular cavity of
EcCaiT near the exit of the closed substrate pathway (Fig. 1a, d and
Supplementary Figs 4 and 7b). In PmCaiT this site is occupied by two
ordered water molecules, linking TM12 to TM8 (Fig. 1e and
Supplementary Fig. 7b). A third water molecule connects Trp 316
to the main-chain carbonyl of Tyr 114 in TM3 and is hydrogen-
bonded to Arg22 of a symmetry-related protomer (Fig. 1e and Sup-
plementary Fig. 7b) in the linker peptide connecting the amino (N)
terminus to a hexa-histidine affinity tag introduced for purification,
which had been removed in EcCaiT before crystallization. The crystal
contact blocks access to the second binding site, which explains why
the site is empty in PmCaiT. Sequence comparison (Supplementary
Fig. 1) suggests that the extracellular site is conserved in BetP. A
second site has also been proposed for LeuT12, but its predicted
position is different and its functional role is unclear.
Substrate binding toCaiT is readilymonitored by Trp fluorescence
(Fig. 3b and Supplementary Fig. 5). The observed changes in fluor-
escence intensity and emission wavelength must reflect the re-
orientation of Trp 323, as no other Trp side chain is subject to a
comparable change of environment upon substrate binding. Assays
were performed both in detergent solution (Supplementary Fig. 5)
and with proteoliposomes (Fig. 3b). Titration of wild-type PmCaiT
with or without NaCl indicated a dissociation constant (Kd) of
2–3mM and a maximal substrate binding concentration Bmax of
1Department of Structural Biology, Max Planck Institute of Biophysics, Max-von-Laue Strasse 3, 60438 Frankfurt am Main, Germany. {Present address: Laboratory of Biophysical
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approximately 40mM for either substrate (Supplementary Table 3).
In Na1-dependent transporters, the substrate-binding affinity with
Na1 increases about fivefold to tenfold13,14. The large difference
between the Michaelis-Menten constant (Km) and Kd is consistent
with more than one functionally significant substrate-binding site.
Transport measurements indicated high substrate specificity
(Fig. 3a). Kinetic analysis of CaiT proteoliposomes preloaded with
c-butyrobetaine gave a value ofKm for L-carnitine of 40–80 mM, and a
maximal transport velocity vmax of about 4,800 nmol substrate per
minute and mg of protein for both wild-type transporters, with or
without NaCl (Supplementary Table 3). Assuming that every CaiT is
active, the calculated uptake rate is roughly 270molecules perminute
(20 uC), similar to BetP13.
Mutations of Met 331 mimicking Na1 in the transport site, or of
Trp 316 in the second binding site, both affect CaiT function.
Replacing Trp 316 by alanine reduces Kd, Km and vmax by factors of
approximately 5, 3.5 and 2.5, respectively (Supplementary Table 3),
indicating that substrate in this site has a profound effect on activity.
Mutating Met 331 to valine reduces Kd for substrate binding by a
factor of around 4, but vmax by a factor of 10 (Supplementary
Table 3), which highlights the pivotal role of this residue for trans-
port. The mutation does not make CaiT Na1 dependent. A simple
side-chain substitution is not sufficient to recreate aNa1-binding site
in this position.
Substrate-binding curves for CaiT reconstituted into proteolipo-






Figure 2 | Hydrogen bond networks in PmCaiT.
a, Hydrogen bonds (dotted) around Glu 111,
connecting TM3 and TM4 to TM8. These helices
must move apart to release the substrate in the
outside-open conformation. b, Arg 262, which
replaces Na2 in the Na1-dependent transporters,
is located betweenTM3 andTM10, stabilizing the







Figure 1 | CaiT structure and bound substrates. a, A cut though the
protomer shows the open cytoplasmic funnel, and the two bound
c-butyrobetaine molecules (arrows). b, The tryptophan box of the central
transport site binds the substrate to be translocated. The Met 331 sulphur
coordinates the substrate (blue; 2Fo2Fc map at 1.0s) by polar interaction
with the carboxyl group (dotted) in EcCaiT, instead of Na1 in the Na1-
dependent transporters4,6. c, In PmCaiT, the Trp 323 indole group (circled)
is rotated by 43u each in x1 and x2, preventing substrate binding. In the
extracellular second binding site of EcCaiT (d), a bound c-butyrobetaine
(contoured as above) is coordinated by cation–p interaction with Tyr 114
and Trp 316, plus an H bond of the c-butyrobetaine carboxyl to the Gly 315
backbone nitrogen. In the substrate-free second binding site of PmCaiT
(e), two water molecules connect TM8 and TM12. A third water molecule
links TM3 to the indole nitrogen of Trp 316, and forms a hydrogen bond to
Arg22 (grey) between the N terminus and His6 tag of a symmetry-related
protomer, blocking the second site.
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Transport is thus allosterically regulated, such that a substrate bound
to one site increases the binding affinity of the other. It is reasonable
to assume that the external substrate-binding site is the regulatory
site. This assumption is strongly supported by our finding that the
PmCaiT structure does not contain bound substrate, whereas that of
EcCaiT does. In PmCaiT, access to the second site is fortuitously
blocked by a crystal contact (Fig. 1e), which cannot form when sub-
strate is bound. An empty regulatory site would reduce the affinity of
the central transport site, which indeed is also empty in PmCaiT.
The affinity of CaiT for c-butyrobetaine is significantly lower than
for L-carnitine (Supplementary Table 3), and this must reflect the
binding properties of the regulatory site. With its extra hydroxyl
group, an L-carnitine molecule in this site can establish another
hydrogen bond to the e-amino group of Lys 470 (Fig. 1d and
Supplementary Fig. 7b), whereas there are no such polar interactions
in the central transport site. Our finding that the Trp 316 mutant is
strongly impaired in transport, but only moderately so in substrate
binding (Supplementary Table 3) supports our conclusion that the
external binding site is regulatory, as the structure of the transport
site, and therefore its affinity for either substrate, will be largely
unaffected by the W316A mutation. If the external site were not
the regulatory site, no strong effect on transport would be expected,
contrary to what we observe (Fig. 3a).
TheHill coefficients derived from thebinding curves (Fig. 3b) range
from 1.4 to 1.7 (Supplementary Table 3), indicative of pronounced
cooperativity. Many allosteric proteins are oligomers, although they
mostly have only one binding site per protomer, whereas CaiT has
two. It is therefore interesting to ask whether the cooperativity applies
to the two binding sites in the protomer, or to all six in the CaiT
trimer6. Substrate binding is accompanied by structural changes both
in the protomer and in the trimer, where the substrate-bound proto-
mer tilts by 3u tilt towards the threefold axis (Supplementary Fig. 7a).
The overall root mean squared deviations (r.m.s.d.) of 0.7 A˚ between
protomers and of 0.9 A˚ between trimers with and without bound
substrate (Supplementary Table 2) indicate that these changes are
significant, given that the r.m.s.d. between spinach and pea LHC-II,
two similarly homologous, trimeric membrane proteins that do not
undergo a conformational change, is 0.35 A˚ (ref. 16). The Hill coef-
ficient greater than 1 signifies an interaction of at least two binding
sites, which are likely to be those we observe in the protomer, as
cooperativity between all six sites in the trimer should result in a
higher Hill coefficient. However, the role of the CaiT trimer6 in allos-
teric regulation remains to be determined.
How might the regulatory site communicate its substrate-bound
state to the transport site? In the occupied regulatory site, bound
substrate displaces two water molecules (Fig. 1d, e and Supplemen-
tary Fig. 7b). This causes small shifts of Tyr 114 (TM3), Trp 316
(TM8), Lys 470 and Gln 473 (TM12) (Supplementary Fig. 7b), which
propagate to Tyr 320 (TM8) and Glu 111 (TM3). The buried Glu 111
that coordinates the network of hydrogen bonds (Fig. 2a) connecting
the two binding sites is conserved in CaiT, BetP and mammalian
OCTN (Supplementary Fig. 1). Replacing this residue by alanine
renders the transporter inactive (Fig. 3a) and destabilizes the trimer
(Supplementary Fig. 6), highlighting its crucial role for CaiT assembly
and function.
These differences add up to small but significant helix movements
in the region between the regulatory site and the transport site. TM3
of EcCaiT tilts out of the substrate pathway by roughly 1 A˚, and TM8
of the other repeat moves in the opposite direction by a similar
distance (Supplementary Fig. 7b). As a result, Trp 142 in the trypto-
phan box and Trp 363 eachmove by approximately 1 A˚. These move-
ments most likely facilitate the replacement of solvent molecules in
the transport site, and the rotation of Trp 323. The latter moves
TM12 out of the substrate pathway by roughly 1 A˚. A similar move-
ment of TM5 makes the EcCaiT transport site more accessible. The
r.m.s.d. values (Supplementary Table 1) and extreme sequence con-
servation of 95% in the TM regions suggest that these differences are
functionally relevant.
Wepropose amechanismof allosterically regulated substrate uptake
by CaiT that encompasses all our findings (Fig. 4). It should be
regarded as speculative, however, until structures of all intermediate
stages have been determined. First, L-carnitine binds to the regulatory
extracellular site. This triggers the re-orientation of Trp 323 in the
central transport site, increasing its substrate-binding affinity. The
open cytoplasmic funnel ensures free access from the cell interior, so
that substrate can bind as soon as Trp 323 re-orients. The substrate
binding from the inside would be c-butyrobetaine, the metabolic
product of L-carnitine.
Transition of CaiT from the fully inside-open to the occluded state
of BetP involves an iris-likemovement of TMhelices surrounding the
transport site (Supplementary Fig. 8), along with the re-orientation
of bulky hydrophobic side chains blocking the pathway. A superposi-
tion of TM helices describes the associated helix movements, which
have been discussed in detail4. When modelled on the outside-open
conformation of LeuT3,4,14,17–20, the extracellular ends of helices TM3
andTM4of CaiTmove by 3.2 and 5 A˚, whereas TM8 andTM12move
by 6.2 and 5 A˚ out of the extracellular substrate pathway. Although
sequence similarity is low (Supplementary Table 1), the overall struc-
tures of the protomers are conserved. In this transition, the hydrogen
bonds between Glu 111, Tyr 320, Tyr 137 and Thr 317 (Fig. 2a) must
break for the outside funnel to open. Several of the hydrogen bonds
around Glu 111 are longer by up to 1.0 A˚ in EcCaiT than in PmCaiT,
suggesting that substrate binding to the external site weakens the
central hydrogen-bonding network.
In the outside-open state, c-butyrobetaine would diffuse out of the
transport site, L-carnitine would bind instead and the process would
go into reverse. The extracellular pathway would close and the cyto-
plasmic funnel would open, releasing L-carnitine to the cell interior.
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Figure 3 | Substrate transportandbinding inCaiT. a, Substrateuptake inwild-
type EcCaiT (pink), wild-type PmCaiT (black) and PmCaiT mutants M331V
(blue), W316A (green) and E111A (red) reconstituted into proteoliposomes in
sodium-free buffer (left) or with 100mM NaCl. b, Binding of c-butyrobetaine
or L-carnitine to PmCaiT reconstituted into proteoliposomes in sodium-free
buffer. Error bars, s.e.m. of triplicate experiments.
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concentration gradient that drives uptake. In the CaiT structure
modelled on the outward-open state of LeuT, the regulatory site
remains intact (Supplementary Fig. 9), suggesting that substrate
remains bound throughout the transport cycle (Fig. 4). When the
external L-carnitine concentration drops below a critical level, the
substrate would diffuse out of the regulatory site, and the transporter
would switch off.
While this paper was under review, an X-ray structure of CaiT
from E. coli at 3.15-A˚ resolution was reported21. It is largely identical
to our structure of the EcCaiT trimer, except that the protomer binds
four molecules of L-carnitine, apparently because of an excess of
this substrate added for crystallization. Two of the binding sites con-
firm those we find to contain c-butyrobetaine, whereas the other two
most likely contain unspecifically bound substrate. Conclusions
about the structural basis of Na1-independent transport have not
been drawn, nor are there any measurements to show cooperative
substrate binding.
METHODS SUMMARY
Genes encoding CaiT from E. coli and P. mirabilis were cloned into pET-15b
(Novagen) and expressed in E. coli strain BL21(DE3) pLysS. Point mutations
were inserted using site-directedmutagenesis. The E. colimembrane fractionwas
solubilized and CaiT was purified by Ni-NTA affinity chromatography. Crystals
were grown in hanging drops. Data sets of native CaiT were collected on the
X10SA beamline at the Swiss Light Source. The structure was determined by
molecular replacement with BetP (Protein Data Bank accession number 2WIT).
The structure of PmCaiT was refined to final working (Rwork) and free (Rfree,
calculated for 5% of the data excluded from refinement) reliability factors of
0.209 and 0.238, respectively. The EcCaiTmodel was refined to an Rwork value of
0.237 and an Rfree value of 0.271, with strict non-crystallography symmetry
restraints enforced during refinement. For transport measurements, CaiT was
reconstituted into liposomes and uptake of [14C]L-carnitine was recorded.
Substrate binding was assayed by tryptophan fluorescence. Binding curves were
evaluated using the program Origin 7.5.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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Figure 4 | Proposed mechanism of cooperative transport. The empty
transporter, represented by the PmCaiT structure, is activated by L-carnitine
(yellow diamond) binding to the regulatory site. This triggers the re-
orientation of Trp 323 (blue disk), and c-butyrobetaine (red diamond) binds
to the central transport site from the cytoplasm. The state in which both
binding sites are occupied is represented by the EcCaiT structure. In the
occluded state, represented by the BetP structure4, the substrate in the
transport site is inaccessible. In the outside-open state, represented by the
LeuT structure6, c-butyrobetaine in the central transport site is replaced by
L-carnitine. CaiT then changes conformation through the occluded state
back to the inside-open state, releasing L-carnitine to the cytoplasm, where it
is metabolized. The next c-butyrobetaine product binds, and the transport
cycle repeats. When the outside L-carnitine concentration drops below a
critical level, the substrate diffuses out of the regulatory site, and the
transporter switches off.
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METHODS
Cloning, expression and protein purification. E. coli BL21(DE3) pLysS cells were
transformedwithplasmids containing the EcCaiT or PmCaiT genes cloned into the
pET-15b (Novagen) vector, using the restriction enzymes NdeI and XhoI.
Recombinant protein was overexpressed at 30 uC in 23YT media supplemented
with 50mgml21 ampicillin and 50mgml21 chlorampenicol. Overexpression of re-
combinant proteinwas inducedwith0.5mMisopropyl-b-D-thiogalactopyranoside
at an absorbance (A600nm) 0.6–0.9. Cells were harvested, homogenized in buffer
containing 25mMHEPES (pH 7.5), 100mMNaCl and 0.1mMPefaBloc (Biomol)
and disrupted using a microfluidizer (Model M-110L, Microfluidics) with three
passes at 60,000 pounds per square inch. Cell debris was removed by centrifugation
(10,000g, 4 uC, 30min), after which membranes were collected by ultracentrifuga-
tion (125,000g, 4 uC, 90min). The membrane pellet was re-suspended in buffer
containing 25mM HEPES (pH 7.5), 100mM NaCl, 2mM Tris[2-carboxyethyl]-
phosphine (TCEP) and 20% glycerol. Aliquots were frozen in liquid nitrogen and
kept at280 uC. Membranes were solubilized by incubation overnight at 4 uC with
2% 5-cyclohexyl-1-pentyl-b-D-maltoside (Cymal-5, Anatrace) and unsolubilized
material was removed by ultracentrifugation (125,000g, 4 uC, 40min). The super-
natant was loaded onto Ni21-chelating sepharose (Amersham) equilibrated with a
buffer containing 25mM HEPES (pH 7.5), 100mM NaCl, 1–2mM TCEP, 0.15–
0.2% Cymal-5 and 20% glycerol. The protein was washed with 50mM imidazole
and elutedwith 200mMimidazole in the samebuffer containing 10%glycerol, and
then with imidazole-free buffer on a PD-10 Sephadex G-25M (GE Healthcare)
column. For tryptophan fluorescence and transport assays, the buffer was replaced
by 50mM Tris (pH 7.5) and 50mM KCl. The His6-tag of EcCaiT was removed
using the Thrombin-Cleavage Kit (Sigma). The purified protein was concentrated
to 5mgml21 (Vivaspin 100 kDa, Sartorius). Site-directed mutagenesis of
Met 331Val and Trp 316Ala of PmCaiT was performed with the QuikChange
SiteDirectedMutagenesisKit (Stratagene) according to themanufacturer’s instruc-
tions. All constructs were verified by nucleotide sequencing.
Crystallization. The protein solution was clarified by centrifugation (100,000g,
4 uC, 30min) before crystallization. Crystals were grown at 4 uC by vapour dif-
fusion in hanging drops of 2 ml protein solution and 1 ml reservoir (50mM
Mg21-acetate or Ca21-acetate (pH 4.5–5.5), 0–200mM NaCl, 19–30%
PEG400). Crystals appeared after 3–10 days. They were frozen directly in liquid
nitrogen using PEG400 as cryoprotectant. The quality of the crystals varied and
pre-screening of a large number was essential. PmCaiT crystals diffracted iso-
tropically to a resolution of 2.3–2.7 A˚. The best EcCaiT crystals diffracted iso-
tropically to a resolution of 3.5 A˚.
Data collection and phasing. Data were collected on beamline X10SA at the
Swiss Light Source (Villigen, Switzerland). Data were initially processed in P1
using XDS22. The correct space group was determined using POINTLESS23 and
data were scaled with SCALA24. PmCaiT crystallized in the space groupH3 with
three molecules in the asymmetric unit arranged around a crystallographic
threefold axis. EcCaiT crystallized in P32 with three molecules in the asymmetric
unit. The structure of PmCaiT was solved by molecular replacement25 with a
poly-alanine model of BetP (Protein Data Bank accession number 2WIT) using
PHASER26, and the structure of EcCaiT by MR with the PmCaiT structure.
Model biaswasminimizedbyusing the prime-and-switchprogram27. Theprimary
density was improved by density modification in RESOLVE28.
Model building and refinement.The structure was refinedwith iterative rounds
of manual rebuilding in COOT29 and O30, and simulated annealing followed by
maximum-likelihood-based energy minimization and isotropic B-factor refine-
ment in PHENIX31. Figures were generated with PovScript132, Povray (http://
www.povray.org) and PyMOL33. Superpositions were performed with the SSM34
superposition routine of COOT29. Superpositions to compute r.m.s.d. values
were performed with the DaliLite server35,36 (http://www.ebi.ac.uk/DaliLite/).
Transport assays.Low-sodiumbuffer for transport and substrate-binding studies
was prepared with sodium-free water (Fluka) and, as far as possible, sodium-free
chemicals. The estimated residual Na1 concentration from the Tris buffer
(Trizmabase, BioUltra, Fluka) was 2.5mM. Purified PmCaiT was reconstituted
into liposomes of E. coli polar lipids (Avanti). Substrate exchange was measured
by recording the uptake of L-[N-methyl-14C]carnitine hydrochloride (14C-L-
carnitine, Perkin Elmer) into CaiT-containing liposomes preloaded with a
saturating concentration of non-radioactive substrate. Usually 10mM of poten-
tial substrate such as glycine (Sigma), glycine betaine (Sigma), c-butyrobetaine
(Lonza) or L-carnitine (Sigma) was used. Proteoliposomes were loaded by two
rounds of freezing and thawing in the presence of substrate. After the second
freeze–thaw cycle the proteoliposomes were extruded first through a 200-nm
membrane filter (Avestin) followed by extrusion through a 400-nm membrane
filter (Avestin). The extraliposomal substrate was removed by ultracentrifugation
(100,000g, 20 uC, 30min), and proteoliposomes used for transport measure-
ments were washed with buffer (50mM KPi (pH 7.5), 1–2mM TCEP).
Substrate uptake was initiated by 2-ml aliquots of the proteoliposome suspension
diluted into 400ml buffer (50mMKPi (pH 7.5), 1–2mMTCEP) with concentra-
tionof 14C-L-carnitine (2.5mCiml21) ranging from6 to620mM.At timepoints of
5–30 s, 14C-L-carnitine uptake was determined with a TRI-CARB 1500 scintil-
lation counter (Canberra-Packard). All transport assays were repeated at least
three times.
Binding assays. Binding assays were performed with 1.5mM purified CaiT
protein in 0.15–0.2% Cymal-5 detergent, or with the transporter reconstituted
into proteoliposomes as above. Concentrations of potential substrates such as
glycine betaine, c-butyrobetaine, L-carnitine or choline ranged from 0.25 to 40
mM. Tryptophan fluorescence emission between 305 and 390 nm was recorded
on a Hitachi F-4500 fluorescence spectrophotometer and averaged over three to
five readings, with the excitation wavelength set to 295 nm and a slit width of 2.5
or 5 nm for excitation or emission, respectively, at different NaCl concentrations
(1–50mM) or without added NaCl. The mean value and standard deviation at
the 342-nm emission maximum was plotted for each substrate concentration.
Data were fitted to the Michaelis–Menten equation2 and apparent Km values
were calculated using the program Origin 7.5. Hill coefficients were determined
by fitting sigmoidal binding curves using the program Origin.
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